October 15, 2024 @ 12:00 pm – 1:00 pm

October 15, 2024 @ 12:00 pm – 1:00 pm

September 27, 2024 @ 12:00 pm – 1:00 pm

Register for this free teams webinar here: https://futurebloodtesting.org/event/2024-09-12
Abstract:
Precision metabolomics and quantification for cost-effective rapid diagnosis of disease are the key goals in personalized medicine and point-of-care testing. At present, patients are subjected to multiple test procedures requiring large laboratory equipment. Here, we present a versatile single complementary metal–oxide–semiconductor chip forming a platform to address personalized needs through on-chip multimodal optical and electrochemical detection that will reduce the number of tests that patients must take. The chip integrates interleaved sensing subsystems for quadruple-mode colorimetric, chemiluminescent, surface plasmon resonance, and hydrogen ion measurements. These subsystems include a photodiode array and a single photon avalanche diode array and an array of ion sensitive field-effect transistors. The sensor arrays are distributed uniformly over an active area on the chip surface in a scalable and modular design. Bio-functionalization of the physical sensors yields a highly selective simultaneous multiple-assay platform in a disposable format. We have demonstrated its versatile capabilities through various applications such as CVD, prostate cancer diagnosis and bleeding disorders monitoring.
Bio:
Dr Chunxiao Hu is a Lecturer in Biomedical Engineering at the University of Glasgow. His research focuses on developing miniaturised portable microsystem platforms by using advanced technologies such as microfluidics, nanofabrication, surface functionalization for biomedical applications. Current projects include Highly integrated chemical sensors (electrical and optical) for multiple detection of biomarkers for early cancer diagnostics; CMOS based ISFET for fast antimicrobial susceptibility testing; Wearable biosensor for continuous monitoring of stroke; Microfluidic device for neurodegenerative diseases; Microfluidic device for electrophysiological analysis of drug uptake in nematodes.
This webinar is part of the Future Blood Testing Network+ Webinar Series. This series will feature a diverse range of speakers who are working in the areas of future blood testing and diagnostics.
The Engineering and Physical Sciences Research Council (EPSRC), in collaboration with the National Institute for Health and Care Research (NIHR), is calling for applications to develop a NetworkPlus focused on the use and development of novel tools and technologies that help people with dementia live independently.
This initiative is designed to support NetworkPlus grants that develop technologies to help people transform their care and health to become more independent at home. Networks should explore and identify the pathways and barriers to implementing these tools and technologies within the health and care system. They should also examine how technologies can be integrated into the home and coordinate care with carers and health and social care professionals, where appropriate
The role of the NetworkPlus is to nurture research ideas among its members and facilitate the transfer of knowledge to a broader community. Networks are encouraged to collaborate with a range of project partners.
🔗 To apply for this funding opportunity, visit: Technologies to enable independence for people living with dementia – UKRI
Key Dates:
Eligibility and Funding Details:
To be successful, proposals need to demonstrate a clear vision, an understanding of the wider context, and the added value arising from the network. Networks should set their research focus within the UK health and social care system, with a particular interest in how tools and technologies could be realistically implemented into the current system.
Don’t miss out on this opportunity!
Apply by 10 September 2024, 4:00pm UK time.
The recent cyber attack on Synnovis has made front-page news over the last few days due to its significant impact on pathology services at London hospitals and the subsequent increased requests for blood donors. The Future Blood Testing Network Plus has consulted researchers, Prof Carsten Maple and Dr Gregory Epiphaniou, from the Secure Cyber Systems Research Group at WMG, University of Warwick, to gain insight into why this attack has severely affected pathology services.
A recent cyber attack has caused significant challenges for NHS Blood and Transplant leading to the organisation issuing an urgent appeal for blood donations.
It is becoming commonplace to read or hear about a new cyber attack in the public or professional media. The UK has seen a sharp rise in severe cyber attacks, particularly those aimed at extorting money from the victim – ransomware attacks. According to the National Cyber Security Centre (NCSC), the number of ransomware attacks surged by over 27% in the past year. The NCSC received 2,005 incident reports in 2023, a 64% increase from the previous year, with 371 of these being severe enough to involve their Incident Management team (NCSC Annual Report, 2023).
Ransomware attacks have impacted a broad spectrum of sectors, from healthcare to cultural institutions such as the British Library attack in October last year.
The rise in ransomware is fuelled by a criminal ecosystem where cybercrime services can be easily procured. This allows attackers to execute ransomware attacks effectively. These criminals typically demand payments in cryptocurrencies including Bitcoin, which are difficult to trace. Even if the ransom is paid, victims may not regain access to all their files (Joint Committee on National Security Strategy, 2023).
The attack early this week on Synnovis, a pathology service provider for major London hospitals, disrupted the ability to match patient blood types. This led to an urgent appeal for O-type blood donors. O Positive blood can be given to anyone with a positive blood type, benefiting three-quarters of the population, while O Negative, known as the universal blood type, can be given to any patient (BBC News, 2024a).
The suspected perpetrators of the attack are the Qilin ransomware cyber gang, a Russian group recognised for operating a ransomware-as-a-service model over the last two years. In this instance, the attackers likely accessed Synnovis’ systems by sending phishing emails. Then, they will then have used IAX Active Directory security to increase their privilege level and propagate throughout the network. To coerce victims into paying the ransom, the Qilin gang uses double extortion, encrypting data and exfiltrating private information. The first extortion concerns requiring a payment in exchange for the decryption keys so that the victim can recover information that is encrypted, and the second requires payment to prevent release of the private information. This latest incident is reflective of a growing pattern of attacks on the healthcare industry, with similar attacks affecting SYNLAB Italia in April 2024 and the NHS Dumfries & Galloway in March 2024.
The NHS has announced that recovery from the attack could take months, and given recent attacks that is likely to be the minimum disruption. The impact of cyber attacks can be profound and long-lasting. The cyber attack on the British Library led to a major technology outage, causing substantial damage. This has required the installation of a new computing infrastructure, and despite efforts to restore services, disruptions persist. In November, the attackers released some of the library’s data onto the dark web, including personal user information (British Library, 2024). It is unknown which information has been captured in the Synnovis breach, but it is likely that at least some of that will be donor personal information and will be released in some way – the attackers wanting to show they will make good on their threats as a message to future victims. It is likely that as with the British Library, Synnovis and the NHS will work with NCSC to understand and recover from the attack. Despite the escalating threat, less than half of organisations have a formal ransomware plan – indeed it has recently been reported that 8% of victims have resorted to paying ransom demands (Thales, 2024).
The increase in cyber attacks underscores the urgent need for robust cybersecurity measures. Organisations need to develop comprehensive plans to address ransomware threats and invest in resilient defenses. Continuous research and investment in cybersecurity are essential to protect critical national infrastructure, maintain public trust, and ensure national security. Addressing these challenges head-on is crucial for the UK’s resilience against the evolving cyber threat landscape (Craig, 2018; Royal Society, 2022).
Authors
Prof Carsten Maple is Director of the NCSC-EPSRC Academic Centre of Excellence in Cyber Security Research and Professor of Cyber Systems Engineering at the University of Warwick. He is also a co-investigator of the PETRAS National Centre of Excellence for IoT Systems Cybersecurity, is the Research Innovation Director at EDGE-AI, the National Edge Artificial Intelligence Hub, and is a Fellow of the Alan Turing Institute.
Dr. Gregory Epiphaniou is an Associate Professor of Security Engineering at the University of Warwick, focusing on bid support, applied research, and publications. His research includes threat source characterisation and wireless communications, mainly on crypto-key generation through V-V channels. He has led and contributed to research projects worth over £20M, funded by EPSRC, IUK, and local authorities. He holds industry certifications in Information Security and has collaborated with the UK MoD. He is a subject matter expert at the Chartered Institute for Securities and Investments, a technical committee member for scientific conferences, and acted as a key member in forming the UK Cybersecurity Council WS5.
References
BBC News, 2024a. O-type blood donors needed after London cyber-attack. [online] Available at: https://www.bbc.co.uk/news/articles/c2eeg9gygyno.
British Library, 2024. British Library cyber incident review. [online] Available at: https://www.bl.uk/home/british-library-cyber-incident-review-8-march-2024.pdf.
Craig, A., 2018. Effective cyber security research can support the resilience of our digital and physical infrastructures.
Joint Committee on National Security Strategy, 2023. A hostage to fortune: ransomware and UK national security. [online] Available at: https://publications.parliament.uk/pa/jt5804/jtselect/jtnatsec/194/report.html.
NCSC Annual Review, 2023. https://www.ncsc.gov.uk/collection/annual-review-2023
Royal Society, 2022. Continuous investment in cybersecurity to counter evolving risks.
Thales, 2024. Thales data threat report reveals rise in ransomware attacks, as compliance failings leave businesses vulnerable to breaches. [online] Available at: https://www.thalesgroup.com/en/worldwide/security/press_release/2024-thales-data-threat-report-reveals-rise-ransomware-attacks.
May 17, 2024 @ 12:00 pm – 1:00 pm

May 3, 2024 @ 12:00 pm – 1:00 pm

Register for this free teams webinar here: https://futurebloodtesting.org/event/2024-04-17
Abstract: Zimmer and Peacock has worked on the development and manufacture of a platform intended to translate academic blood testing assays from the lab into the clinical setting, and onto the market. At ZP, for research to be impactful and sustainable, it does need to be presented in a form factor so that it can be easily used by clinicians and patients. In this webinar and live streaming demo, ZP will show how a scientific paper can easily become a clinical product. The policy at ZP is to translate science into regulatory approved products in 2 years or less.
Bio: Martin Peacock is an industrial bioelectrochemist with over twenty years of biosensor experience, having had industrial roles from Abbott Diabetes to GSK, and solving technical challenges from continuous glucose monitoring to RNA analysis. He is a Director at Zimmer and Peacock Ltd, a company that sees sensors as a critical part of various social and commercial revolutions, such as the Internet of Things (IoT), Sensor Web, and the Invitro Diagnostics Market (IVD). With over eight years of experience in this role, he lead a team of talented scientists and engineers who partner with academia and industry to develop and manufacture innovative sensors and medical diagnostics.
This webinar is part of the Future Blood Testing Network+ Webinar Series. This series will feature a diverse range of speakers who are working in the areas of future blood testing and diagnostics.
Register for this free teams webinar here: https://futurebloodtesting.org/event/2024-03-26
Abstract: The idea of conducting tests for an infectious disease on the kitchen table would have seemed unimaginable only three years ago; now, it is a routine part of life in the UK. Similarly, measuring health markers such as heart rate or blood pressure used to involve a trip to your GP’s surgery; now, they are measured by your watch. Routine testing of cellular function may be the next step, supplying data on cellular changes that occur before the presentation of symptoms or rapidly assessing the efficacy of therapies. Platelets play a vital role in chronic and acute cardiovascular disease but also have roles in immunity, inflammation, cancer metastasis, Alzheimer’s disease and infections, such as dengue, HIV-1, malaria, and COVID-19. In addition, they are easily obtained from subjects or patients, making them valuable biomarkers for changes in blood vessels associated with disease, ageing or therapy. This seminar will introduce the utility of platelets as a cellular biomarker and the progress we have made in designing tests that capture the function of these cells, both in the lab and at point-of-care.
Bio: Chris Jones is an Associate Professor of the Thrombosis and Heamostasis in the school of Biological Sciences at the University of Reading. Over two decades, he has designed and employed innovative platelet function assays to provide novel insights into platelet dysfunction. His lab has also developed analysis software for platelet activation assays and employed microfluidics, open hardware and smartphone technology to develop low-cost point-of-care platelet function assays. These new technologies have led to HaemAnalytica, a soon-to-be established spinout, which will provide complete platelet function analysis for clinical trials and diagnostics.
This webinar is part of the Future Blood Testing Network+ Webinar Series. This series will feature a diverse range of speakers who are working in the areas of future blood testing and diagnostics.
Registration Link: https://www.store.reading.ac.uk/conferences-and-events/henley-business-school/workshops/the-future-of-healthcare-remote-blood-testing-monitoring-ai
Formal Event Flyer: https://futurebloodtesting.org/fbtn2023/eventflyer
Description:
At the Future Blood Testing Network Plus, we are aiming to build a multi-disciplinary community to develop digital health technologies for remote, rapid, affordable and inclusive monitoring and personalised analytics. This two day workshop will feature speakers to discuss the future of healthcare, remote blood testing, monitoring and artificial intelligence (AI).
This event will take place at Leonardo Hotel Southampton (Formerly Jurys Inn). Both days will include lunch and coffee breaks, with day 1 also including a drinks reception with dinner.
NB: Due to venue policies on final numbers we cannot guarantee that we can cater to all dietary requirements after the 12th October.
Event Costs
Draft Agenda
Day 1 – 7th November
Day 2 – 8th November